Skip to main content
Smart Investors Daily
BioLargo, Inc. logo

OTC · BLGO

BioLargo, Inc.

Basic Materials · Chemicals

$0.10

Up+$0.02 (+19.88%)

Updated Aug 22, 2026, 5:37 PM

SID Score

4.0/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
56.59M
P/E ratio
-5.65
Dividend yield
0.00%
52-week range
— – —
Volume
676.19K
Avg. volume
514.93K

Price performance

BLGO price history

1M range · 0 trading sessions · Daily adjusted prices

BLGO does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest BLGO news

The latest Smart Investors Daily articles mentioning BLGO.

BLGO research

Overview

Company profile and research snapshot.

Company profile

BIOLARGO INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

accessnewswire.com · Dec 3, 2025

BioLargo Subsidiary BEST Featured in Chemical Engineering Magazine for PFAS Breakthrough

Lake Stockholm, NJ AEC System Delivered and Preparing to Go Live WESTMINSTER, CALIFORNIA / ACCESS Newswire / December 3, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator focused on sustainable water and environmental solutions, announced that its subsidiary, BioLargo Equipment Solutions & Technologies, Inc., has been prominently featured in Chemical Engineering magazine for its advances in electrostatic PFAS ("forever chemicals") treatment technology. The article, titled "Electrostatic PFAS Capture Produces Nearly Zero Waste," highlights the performance benefits of BioLargo's Aqueous Electrostatic Concentrator (AEC) platform, including its ability to remove long-, short-, and ultra-short-chain PFAS while generating dramatically less waste than conventional treatment methods.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.